Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ONCY

ONCOLYTICS BIOTECH (ONCY) stock: insider trades, news & valuation

Strong buying
Close · Oct 9, 2026 $0.56 +3.7% on the day -54.8% over 12 months 52-week range $0.54 – $1.27

Share price and insider trades

ONCY closeInsider buyInsider sale
0.500.751.001.251.50NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $4,848 on 2026-03-12 · Jared KellyBought $10,300 on 2026-03-11 · James T. ParsonsBought $79,960 on 2026-02-11 · Andrew Aromando, Bernd R. Seizinger, Jared KellyBought $104,000 on 2026-01-16 · Bernd R. SeizingerBought $164,124 on 2026-02-12 · Allison Hagerman, Bernd R. Seizinger, Deborah Margaret Brown, Jared Kelly, Kirk Look, Patricia S Andrews, Thomas Charles Heineman, Wayne Pisano
Bought, 12 months$345K
Sold, 12 months$0
Insiders buying9
Insiders selling0

ONCOLYTICS BIOTECH insider trading at a glance (Oct 9, 2026): in the past 12 months, 9 insiders bought $345K and 0 sold $0 of ONCY stock on the open market, including a cluster buy that began Feb 11, 2026.

ONCY insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $363K bought (14 trades)$363KQ1 2026Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0—0
Q1 2026$363K14—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.4×Last 5 sessions
Insiders' paper profit−$137KOn all tracked purchases -37.7%

Summary

Over the past 12 months, 9 ONCOLYTICS BIOTECH INC insiders reported open-market purchases totaling $345K, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Feb 11, 2026, when 8 insiders bought a combined $231K. Among insiders with enough purchase history to measure, Bernd R. Seizinger (Director) has the highest Insider Score at 33.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Mar 13SEC James T. ParsonsDirector Buy 10,00041,849 held (+31%) $1.03 $10K -45.6% —
Mar 13SEC Jared KellyCEO Buy 5,050114,050 held (+5%) $0.96 $5K -41.7% —
Feb 13SEC Bernd R. SeizingerDirector Buy 60,000526,991 held (+13%) $0.83 $50K -32.5% 33
Feb 13SEC Bernd R. SeizingerDirector Buy 40,000566,991 held (+8%) $0.85 $34K -34.1% 33
Feb 13SEC Patricia S AndrewsDirector Buy 35,40078,128 held (+83%) $0.86 $30K -34.9% —
Feb 13SEC Andrew AromandoChief Business Officer Buy 29,60055,100 held (+116%) $0.86 $25K -34.9% —
Feb 13SEC Wayne PisanoDirector Buy 30,000492,414 held (+6%) $0.84 $25K -33.3% 20
Feb 13SEC Jared KellyCEO Buy 29,500109,000 held (+37%) $0.84 $25K -33.3% —
Feb 13SEC Deborah Margaret BrownDirector Buy 25,000109,851 held (+29%) $0.85 $21K -34.1% —
Feb 13SEC Kirk LookCFO Buy 12,000287,515 held (+4%) $0.84 $10K -33.3% —
Feb 13SEC Thomas Charles HeinemanChief Medical Officer Buy 12,132282,818 held (+4%) $0.83 $10K -32.5% —
Feb 13SEC Allison HagermanVp, Product Development Buy 10,000115,059 held (+10%) $0.83 $8K -32.5% —
Feb 13SEC Jared KellyCEO Buy 5,60079,500 held (+8%) $0.84 $5K -33.3% —
Jan 20SEC Bernd R. SeizingerDirector Buy 100,000466,991 held (+27%) $1.04 $104K -46.2% 33

Insiders at ONCOLYTICS BIOTECH INC

InsiderBoughtSoldLast filingScore
Bernd R. SeizingerDirector $188K — Feb 13, 2026 33
Jared KellyCEO $34K — Mar 13, 2026 —
Patricia S AndrewsDirector $30K — Feb 13, 2026 —
Andrew AromandoChief Business Officer $25K — Feb 13, 2026 —
Wayne PisanoDirector $25K — Feb 13, 2026 20
Deborah Margaret BrownDirector $21K — Feb 13, 2026 —
James T. ParsonsDirector $10K — Mar 13, 2026 —
Kirk LookCFO $10K — Feb 13, 2026 —
Thomas Charles HeinemanChief Medical Officer $10K — Feb 13, 2026 —
Allison HagermanVp, Product Development $8K — Feb 13, 2026 —

ONCY stock: common questions

Are ONCOLYTICS BIOTECH INC insiders buying ONCY stock?

In the past 12 months, 9 insiders reported open-market purchases of ONCY worth $345K. The latest was Director James T. Parsons bought $10K of ONCY at $1.03 — first open-market purchase in our records; raises the stake by 31%.

Are ONCOLYTICS BIOTECH INC insiders selling ONCY stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ONCY's 52-week range?

Over the past year ONCY has traded between $0.54 and $1.27. It last closed at $0.56 on Oct 9, 2026.